Table 2 CMR imaging findings in HCM patients and controls
Parameter | Controls (n = 30) | Patients (n = 63) | p-value |
|---|---|---|---|
EF (%) | 62.5 ± 7.9 | 65.5 ± 6.8 | 0.07 |
CO (L) | 4.1 (3.5, 5.8) | 5.4 (4.7, 6.9) | 0.03 |
EDV (mL) | 111.0 ± 23.5 | 122.1 ± 32.5 | 0.10 |
ESV (mL) | 39.2 (33.5, 50.6) | 40.9 (32.9, 47.8) | 0.90 |
SV (mL) | 69.6 ± 18.7 | 80.3 ± 24.0 | 0.04 |
EDV/BSA (mL/m2) | 62.9 ± 12.3 | 68.6 ± 15.3 | 0.08 |
ESV/BSA (mL/m2) | 23.1 (18.7, 27.8) | 23.1 (18.7, 27.7) | 0.90 |
SV /BSA (mL/m2) | 39.3 ± 9.7 | 45.0 ± 11.4 | 0.02 |
LV mass (g) | 72.5 (64.8, 82.4) | 121.4 (100.3, 138.9) |  < 0.001 |
LV mass/BSA (g/m2) | 41.8 (37.3, 44.8) | 68.5 (59.0, 79.3) |  < 0.001 |